Supplements to Regulate Periods With PCOS: The Honest Evidence Ranking
10 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
No supplement restores ovulation reliably in PCOS, and a bleed is not proof it happened. Myo-inositol has the most trial data — 4 g daily restored a cycle in 70–88% of women within 3–6 months — while NAC, cinnamon and vitex have far thinner evidence. A period absent 90+ days needs a thyroid and prolactin work-up first, not a supplement.
Why a Missed Period Needs a Work-Up Before Any Supplement
Ninety days without a period is the point the 2023 international guideline treats as needing evaluation, regardless of how many periods happened earlier in the year (Teede et al., 2023). That threshold exists because two things can be going on underneath a missed period that no supplement touches: a non-PCOS cause producing the same symptom, and an endometrial lining that keeps thickening under unopposed oestrogen the longer a cycle runs without ovulation. Thyroid dysfunction and elevated prolactin both stop periods in a way that looks identical to PCOS on the surface, and neither responds to inositol, NAC, cinnamon, or vitex — they need their own blood test and, often, their own treatment. The full criteria for what counts as irregular by cycle length and cycle count are covered in PCOS irregular periods; the endometrial risk of letting a long gap run is covered in PCOS endometrial hyperplasia.
A Period Is Not the Same as a Restored Cycle
The actual goal is ovulation, not a bleed, and the two do not always travel together. In the largest inositol ovulation trial, 22 of 25 women (88%) restored at least one spontaneous menstrual cycle on 4 g of myo-inositol daily, but only 18 of the 25 (72%) went on to maintain normal ovulatory activity through follow-up — a real gap between “a period happened” and “ovulation is actually restored and sustained.” A withdrawal bleed brought on by a progestin course is an even starker version of the same distinction: it protects the uterine lining, and it looks like a period, but it confirms nothing about ovulation. How to induce a period with PCOS covers exactly what that kind of bleed does and does not mean. Every ranking below is judged on the harder standard — ovulation and sustained cyclicity — not on whether a bleed showed up once.
Which Supplement Has the Most Trial Data for PCOS Cycles?
Myo-inositol has more randomized trial data behind it than any other supplement sold for PCOS periods, and it is the only one the 2023 guideline addresses by name. Four separate placebo- or comparator-controlled trials measured cycle or ovulation outcomes directly:
| Trial | Population | Dose & duration | Result |
|---|---|---|---|
| Papaleo 2007 | 25 women, oligo/amenorrhoea | 4 g myo-inositol + folic acid/day, 6 months | 22/25 (88%) restored ≥1 cycle; 18/25 (72%) sustained ovulation |
| Costantino 2009 | 42 women, PCOS with oligomenorrhoea | 4 g myo-inositol + folic acid/day, 12–16 weeks | 16/23 (70%) ovulated vs 4/19 (21%) on placebo |
| Genazzani 2008 | 20 overweight women, PCOS (n=10 per arm) | 2 g myo-inositol/day, 12 weeks | Cyclicity restored in all 10 amenorrhoeic/oligomenorrhoeic subjects on myo-inositol; none on folic acid alone |
That third result — 10 out of 10 — is a real finding, and it is also a trial small enough that one or two more non-responders would have changed the headline number substantially; treat “restored in all subjects” as a promising signal from a small study, not a guarantee. In the Costantino trial, total testosterone also fell from 99.5 to 34.8 ng/dL on myo-inositol against almost no change on placebo (p = 0.003), alongside the ovulation difference above.
The guideline itself grades inositol’s overall benefit as very-low certainty: it “could be considered … noting limited harm, potential for improvement in metabolic measures, yet with limited clinical benefits including in ovulation, hirsutism, or weight” (Rec 4.7.1), and for two specific outcomes it prefers a different drug outright — “metformin should be considered over inositol for hirsutism and central adiposity” (Rec 4.7.2). That is a more cautious read than the individual trial numbers above suggest on their own, and both things are true at once: the trials above are real, and the body that reviewed all of them together still calls the overall case thin. Inositol for PCOS covers the full dose, ratio and timeline picture this article only summarises.
What About NAC for Irregular Periods With PCOS?
NAC (N-acetylcysteine) has the second-largest trial base of any supplement asked about for PCOS periods, built entirely around ovulation rather than cycle frequency directly. A 2015 meta-analysis pooling 910 women across 8 randomized trials found higher odds of ovulation and pregnancy with NAC than with placebo, with no significant difference from placebo on BMI, testosterone or insulin — meaning whatever NAC does for ovulation does not show up as a broader metabolic effect. That review also reported a live-birth benefit, and that particular figure should now be set aside: it drew on a trial retracted in November 2025, which was the only individual PCOS trial to report a live-birth rate for NAC at all. The ovulation and pregnancy findings rest on other trials and stand. Every head-to-head trial in that same pooled dataset found metformin more effective than NAC at achieving ovulation, in some comparisons by a wide margin. NAC’s evidence base is real but narrower than inositol’s, and it has never been tested as a treatment for cycle length or frequency as its own outcome — only as an aid to ovulation induction, often alongside clomiphene.
Does Cinnamon Regulate PCOS Periods?
One trial has tested cinnamon against a menstrual-cyclicity outcome directly, and it is worth reading for what it did and did not show. Over 6 months, 45 women with PCOS given 1.5 g of cinnamon daily had more frequent cycles than those on placebo — a median of 0.75 cycles per month versus 0.25 (p = 0.0085), with cyclicity improving by 0.23 cycles per month from baseline. That is a genuine, statistically reported cycle-frequency effect. It also came from a trial that lost more than 60% of its enrolled participants before the 6-month endpoint, and insulin resistance and androgen levels did not move in the same women — which means the trial cannot actually explain why cycles improved, only that they did in the smaller group that completed it. Treat this as one small, preliminary signal, not an established effect.
Does Vitex (Chasteberry) Help PCOS Cycles?
Vitex has the thinnest trial base of the four covered here, and its one mechanism has nothing to do with the insulin or androgen pathways that drive most PCOS cycle irregularity. Vitex compounds bind the dopamine D2 receptor and lower prolactin; a single small 2026 trial of 60 women with PCOS tested it for 12 weeks against oxidative stress as its primary outcome, and menstrual frequency increased as a secondary finding alongside improved insulin resistance and hirsutism scores. One trial, one centre, a secondary outcome — this is a reason to watch the space, not to treat vitex as a period-regulation option with evidence behind it. Because vitex acts on dopamine and prolactin, it should not be combined with a dopamine agonist, an antipsychotic, or any hormonal PCOS treatment without a prescriber’s input, and it has not been tested in pregnancy — stop it as soon as pregnancy is suspected rather than waiting for a missed period to confirm it. The full mechanism and interaction picture is in vitex for PCOS.
Ranked: What the Trial Evidence Actually Supports
| Rank | Supplement | Trial base | Best cycle/ovulation number | Honest verdict |
|---|---|---|---|---|
| 1 | Myo-inositol | 4 controlled trials with cycle/ovulation endpoints | 70–88% ovulated or restored a cycle vs 21% placebo | Most data, but graded very-low certainty by the guideline |
| 2 | NAC | 8 pooled RCTs, 910 women | Higher ovulation odds than placebo; loses to metformin head-to-head | Real for ovulation, not tested on cycle frequency itself |
| 3 | Cinnamon | 1 trial, 45 women, >60% dropout | 0.75 vs 0.25 cycles/month (p = 0.0085) | Preliminary; mechanism unexplained by insulin or androgens |
| 4 | Vitex | 1 trial, 60 women, secondary outcome | Menstrual frequency increased (secondary finding) | Thinnest evidence; wrong mechanism for most PCOS phenotypes |
Resveratrol is sometimes added to this list too, on the strength of one PCOS trial that lowered testosterone and improved insulin sensitivity — but that trial never measured cycles or ovulation as an outcome at all, so it has no place in a period-regulation ranking specifically. Resveratrol for PCOS covers what that trial actually found.
Who This Ranking Will Not Help
- Anyone who has not been worked up for thyroid disease or high prolactin. Every trial above enrolled women whose oligo- or amenorrhoea was already established as PCOS-driven — none of these supplements has a mechanism for a thyroid or prolactin cause.
- Anyone who has gone 90 or more days without a period and hasn’t seen a clinician. That gap is a work-up threshold, not a supplement-shopping decision — see the callout above.
- Anyone whose goal is a monthly bleed specifically, rather than ovulation. A progestin-induced withdrawal bleed achieves that goal directly and is a clinical option worth discussing; none of the four supplements above have been shown to do the same thing faster or more reliably.
- Anyone expecting a result inside a few weeks. The fastest trial above (Genazzani, 12 weeks) is still three months; most ran longer.
You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), the name a 2026 global consensus of more than 50 organisations gave the same condition. Nothing about the trial evidence above changes under either name; this article uses PCOS because that is still what most readers search.
For the wider supplements and medications section — every option ranked against each other on all the outcomes they target, not just cycles — see the full evidence-ranked supplements guide.
Common questions
What supplements help regulate periods with PCOS?
Myo-inositol has the most trial data, restoring a cycle or ovulation in 70–88% of treated women across small trials versus around 21% on placebo. NAC has pooled ovulation data from 910 women; cinnamon and vitex each rest on a single, heavily caveated trial.Is there a natural way to regulate periods with PCOS?
The trial evidence for any supplement is modest, and the guideline grades inositol — the best-studied option — as very-low certainty with limited clinical benefit. A diagnostic work-up for thyroid and prolactin causes, done first, changes outcomes more reliably than any supplement tested so far.What are the best supplements for irregular periods with PCOS?
Ranked by trial evidence for cycle or ovulation outcomes specifically: myo-inositol first, NAC second, cinnamon and vitex tied for weakest, each resting on one small trial.How long do period-regulating supplements take to work for PCOS?
The fastest positive trial result took 12 weeks (Genazzani, inositol); most ran 3 to 6 months. No trial found a meaningful cycle change inside a single month.Does myo-inositol guarantee a period will return?
No. In the largest ovulation trial, 88% restored at least one cycle, but only 72% went on to sustain ovulation through follow-up — a bleed and a restored ovulatory cycle are not the same outcome.When should I see a doctor instead of trying a supplement for irregular periods?
At 90 days or more without a period, per the international guideline's own threshold — that gap needs a thyroid and prolactin check and an assessment of endometrial risk, not a supplement tried first.
- PCOS Supplement Routine: Morning vs Night, Per the TrialsNo PCOS trial tested a full morning-vs-night supplement routine. What each supplement's own trials actually specified, assembled into one realistic daily plan.
- Alpha-Lipoic Acid vs Berberine for PCOS: Different Jobs, Different EvidenceAlpha-lipoic acid and berberine are sold as interchangeable PCOS insulin sensitisers. Their mechanisms, evidence, and safety profiles are not the same.
- Ashwagandha for PCOS: The Real Evidence and the Real RisksNo PCOS trial has tested ashwagandha on cycles, androgens or insulin — only cortisol trials in people without it. The liver, thyroid and pregnancy risks.
- Ashwagandha vs Holy Basil for PCOS: Which Adaptogen Is Actually Safer?Neither has a PCOS trial. How ashwagandha's liver and thyroid risks compare to holy basil's antifertility and bleeding signals, so you can pick the safer one.
Sources
- 1.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 2.Papaleo E, Unfer V, Baillargeon JP, et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol. 2007.
- 3.Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci. 2009.
- 4.Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008.
- 5.Fitz V, Graca S, Mahalingaiah S, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024.
- 6.Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol. 2014.
- 7.Thakker D, Raval A, Patel I, Walia R. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015.
- 8.Hatami A, Seidi F, Khosrowbeygi A, Moslemi A, Jalali-Mashayekhi F. The Effect of Vitex Agnus-Castus Plant on Some Markers of Oxidative Stress, Lipid Profile and Insulin Resistance in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind Controlled Clinical Trial Study. JBRA Assist Reprod. 2026.
- 9.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.